Trial · NCT06236061
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | [Core Part] Change from baseline to Week 8 in msSBP | Baseline, Week 8 | Change from baseline to Week 8 in mean sitting systolic blood pressure (msSBP) |
| Secondary | [Core Part] Change from baseline to Week 8 in maSBP | Baseline, Week 8 | Change from baseline to Week 8 in mean 24-hour ambulatory systolic blood pressure (maSBP) |
| Secondary | [Core Part] Proportion of patients achieving a blood pressure control after 8 weeks of treatment | 8 weeks | Proportion of patients achieving a blood pressure control (msSBP \<140 mmHg and msDBP \<90 mmHg) after 8 weeks of treatment |
| Secondary | [Core Part] Change from baseline to Week 8 in msDBP | Baseline, Week 8 | Change from baseline to Week 8 in mean sitting diastolic blood pressure (msDBP) |
| Secondary | [Core Part] Change from baseline to Week 8 in maDBP | Baseline, Week 8 | Change from baseline to Week 8 in mean 24-hour ambulatory diastolic blood pressure (maDBP) |
| Secondary | [Core Part] Proportion of patients achieving a msSBP response after 8 weeks of treatment | 8 weeks | Proportion of patients achieving a msSBP response (\<140 mmHg or a reduction ≥20 mmHg from baseline) after 8 weeks of treatment |
| Secondary | [Core Part] Proportion of patients achieving a msDBP response after 8 weeks of treatment | 8 weeks | Proportion of patients achieving a msDBP response (\<90 mmHg or a reduction ≥10 mmHg from baseline) after 8 weeks of treatment |
| Secondary | [Core Part] Change from baseline to Week 8 in daytime, nighttime and early morning maSBP | Baseline, Week 8 | Change from baseline to Week 8 in daytime, nighttime and early morning maSBP |
| Secondary | [Core Part] Change from baseline to Week 8 in daytime, nighttime and early morning maDBP | Baseline, Week 8 | Change from baseline to Week 8 in daytime, nighttime and early morning maDBP |
| Secondary | [Core Part] Number of patients with treatment-emergent adverse events | Up to 8 weeks | Number of patients experiencing treatment-emergent adverse events including (but not limited to) any unfavorable and unintended signs, symptoms or disease, abnormal vital signs, electrocardiogram data, safety lab measurements that induce clinical signs or symptoms, are considered clinically significant or require therapy |
| Secondary | [OLE Part] Number of patients with treatment-emergent adverse events | Up to 52 weeks | Number of patients experiencing treatment-emergent adverse events including (but not limited to) any unfavorable and unintended signs, symptoms or disease, abnormal vital signs, electrocardiogram data, safety lab measurements that induce clinical signs or symptoms, are considered clinically significant or require therapy |
| Secondary | [OLE Part] Change from baseline in msSBP and msDBP | Baseline, Week 4, Week 8, Week 13, Week 26, Week 39, and Week 52 of OLE part | Change from baseline in msSBP and msDBP by visit in OLE part |
| Secondary | [OLE Part] Proportion of patients achieving blood pressure control, msSBP response and msDBP response | Over 52 weeks | Proportion of patients achieving blood pressure control (msSBP \<140 mmHg and msDBP \<90 mmHg), msSBP response (\<140 mmHg or a reduction ≥20 mmHg from baseline) and msDBP response (\<90 mmHg or a reduction ≥10 mmHg from baseline) by visit |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06236061/registered